Condition Center: Revlimid

Blood Cancer Rx Trial Halted

The purpose of clinical trials is to study the safety and effectiveness of a medication. Sometimes, clinical trials involving humans find that a medi...

Personalizing Blood Cancer Treatment

Huge advances have been made in the understanding of multiple myeloma. There are a variety of approaches for treating this blood cancer. The trick is...

Closing In on a Cure

Someone diagnosed with any type of leukemia in the early 1960s had about a 14 percent chance of being alive five years later. Today, those chances ar...

New Rx for Advanced Multiple Myeloma

Multiple myeloma is a blood cancer that affects nearly 22,000 Americans every year. It develops in mostly older people when plasma cells in the bone ...